Dr. Xiyan Wang 王喜艳
Chief Physician, Associate Professor
Department of Gastrointestinal Surgery, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: General surgery, with a focus on pancreatic and splenic conditions.
Dr. Wang is Chief Physician, Associate Professor, and Doctoral Supervisor at the Affiliated Cancer Hospital of Xinjiang Medical University, where Dr. Wang serves as Deputy Party Secretary and President. For the past ten years, Dr. Wang has focused on pancreatic surgery. Dr. Wang contributed to five editions of the national textbook Surgery and served as deputy editor-in-chief of Guide to Medical Disputes.
Professional roles
- Member, Chinese Medical Association
- Standing Committee Member, Surgical Branch of Chinese Medical Doctor Association
- Vice Chair, Surgical Branch of Xinjiang Medical Association
- Editorial Board Member, Chinese Journal of Digestive Surgery
Name order: in Chinese the family name comes first (Wang Xiyan). Papers usually list the name as Xiyan Wang or Wang X.
Selected publications
23 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Medicine (Baltimore), 2020 (senior author): Expression and clinical significance of p62 protein in colon cancer. PubMed 32011477
- Oncol Lett, 2018 (senior author): Interaction of polymorphisms in xeroderma pigmentosum group C with cigarette smoking and pancreatic cancer risk. PubMed 30344718
- Oncol Lett, 2018 (senior author): Expression of Smo in pancreatic cancer CD44(+)CD24(+)cells and construction of a lentiviral expression vector to silence Smo. PubMed 30250551
- Oncol Lett, 2018 (senior author): Significance and prognosis of epithelial-cadherin expression in invasive breast carcinoma. PubMed 30008850
- Genet Mol Biol, 2018 (senior author): Contribution of DNA repair xeroderma pigmentosum group D genotypes to pancreatic cancer risk in the Chinese Han population. PubMed 29260835
- J Huazhong Univ Sci Technolog Med Sci, 2016 (senior author): HLA-A*02-B*46 haplotype: an adverse prognostic factor in Han patients with nasopharyngeal carcinoma. PubMed 27752910
- Front Med China, 2010 (first author): Influence of the adjuvant therapy on the survival of patients with stage II pancreatic carcinoma. PubMed 21191747
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion